510(k) Report

510(k) · Cleared

Cleared

Collagen Matrix Anorganic Bone Mineral Bone Graft Materials

K062200510(k) TraditionalCleared Feb 13, 2007196-day reviewClass II21 CFR 888.3045

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Collagen Matrix, Inc. · MQV Filler, Bone Void, Calcium Compound

Cleared on Feb 13, 2007 as substantially equivalent to K014289 (Geistlich-Pharma, 2002) and 2 other predicates after a 196-day review. Its family tree reaches back 3 generations to 1987.

Decided
Feb 13, 2007
Review
196 days
Class
Class II
Product code
MQV
Recalls
None
Predicates
3

Its longest line of descent runs back 3 generations to K871773 (1987). 12 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 2003: 1 other ancestor2002: 2 other ancestors2000: 1 other ancestor1998: 2 other ancestors1995: 2 other ancestors1992: 1 other ancestorK871773 · Bio-Oss Pure Nat Hydroxyapatite Endoss Implant · Geistlich-Pharma · 1987K033815 · Bio-Oss, Bio-Oss Blocks and Bio-Oss Collagen · Geistlich-Pharma · 2004K043034 · Osteoguide Anorganic Bone Mineral Products · Collagen Matrix, Inc. · 2005 · recalled19851990199520002005
Other ancestors, by generation 1 generation back: 2 other ancestors2 generations back: 4 other ancestors3 generations back: 3 other ancestors K043034 · Osteoguide Anorganic Bone Mineral Products · Collagen Matrix, Inc. · 2005 · recalledK033815 · Bio-Oss, Bio-Oss Blocks and Bio-Oss Collagen · Geistlich-Pharma · 2004K871773 · Bio-Oss Pure Nat Hydroxyapatite Endoss Implant · Geistlich-Pharma · 19870
  1. Root · 3 generations backK871773 Bio-Oss Pure Nat Hydroxyapatite Endoss ImplantGeistlich-Pharma · 1987
  2. 2 generations backK033815 Bio-Oss, Bio-Oss Blocks and Bio-Oss CollagenGeistlich-Pharma · 2004
  3. 1 generation backK043034 Osteoguide Anorganic Bone Mineral ProductsCollagen Matrix, Inc. · 2005 · Recalled
  4. This deviceK062200 Collagen Matrix Anorganic Bone Mineral Bone Graft MaterialsCollagen Matrix, Inc. · 2007
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K871773Bio-Oss Pure Nat Hydroxyapatite Endoss ImplantGeistlich-Pharma1987—
−2K033815Bio-Oss, Bio-Oss Blocks and Bio-Oss CollagenGeistlich-Pharma2004—
−1K043034Osteoguide Anorganic Bone Mineral ProductsCollagen Matrix, Inc.20053
0 (this device)K062200Collagen Matrix Anorganic Bone Mineral Bone Graft MaterialsCollagen Matrix, Inc.2007—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199210
199520
199820
200010
200220
200310
FIG. 1 — Lineage of K062200, 1987–2007Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MQV? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MQV device

  1. #1 K232315 Catalyst Bone Void Fillerscore 25.2 · 25 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K014289Orthoss Resorbable Bone Void Filler
Summary page 1
…888.3045 Device Class: Class II Product Code: MQV Predicate Device(s): ORTHOSS TM Resorbable Bone Void Filler, K014289 VITOSS® Scaffold Synthetic Cancellous Bone Void Filler, K03…
Geistlich-Pharma2002—
*K032409Vitoss Scaffold Synthetic Cancellous Bone Void Filler
Summary page 1
…OSS TM Resorbable Bone Void Filler, K014289 VITOSS® Scaffold Synthetic Cancellous Bone Void Filler, K032409 OsteoGuide® Anorganic Bone Mineral Products, K043034 Description of the Device Collagen Matr…
Orthovita, Inc.2003—
*K043034Osteoguide Anorganic Bone Mineral Products
Summary page 1
…caffold Synthetic Cancellous Bone Void Filler, K032409 OsteoGuide® Anorganic Bone Mineral Products, K043034 Description of the Device Collagen Matrix Anorganic Bone Mineral Bone Graft Materials are natural, porous bone mineral matrices…
Collagen Matrix, Inc.20053

Also cleared against K014289: 3 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 20 years and passes through 2 companies; a new generation was cleared every 1.6 years on median.
  • 1 of the 12 ancestors has a recall of any class.
  • 3 other devices also cite its predicate K014289.

How does its category compare?

All MQV devices

MQV Filler, Bone Void, Calcium Compound: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · MQV

14in 2025

2007: 352008: 322009: 232010: 172011: 162012: 92013: 122014: 202015: 182016: 82017: 172018: 232019: 132020: 152021: 82022: 92023: 212024: 282025: 142026 (partial year): 5
2007high 35 (2007) · low 8 (2016)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MQV

57in 2025

2007: 144 days median2008: 102 days median2009: 180 days median2010: 147 days median2011: 92 days median2012: 107 days median2013: 197 days median2014: 153 days median2015: 184 days median2016: 214 days median2017: 124 days median2018: 124 days median2019: 90 days median2020: 132 days median2021: 88 days median2022: 118 days median2023: 74 days median2024: 55 days median2025: 57 days median2026 (partial year): 96 days median
2007high 214 (2016) · low 55 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MQV

1in 2025

2007: 52008: 32009: 12011: 62012: 32013: 22016: 12017: 12018: 22020: 12023: 32024: 22025: 12026 (partial year): 4
2007high 6 (2011) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MQV

57in 2025

2007: 672008: 712009: 812010: 682011: 1142012: 1492013: 2232014: 1112015: 1252016: 1062017: 1072018: 862019: 652020: 1262021: 1012022: 472023: 1202024: 682025: 57
2007high 223 (2013) · low 47 (2022)2025

MAUDE reports naming product code MQV, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200735144567
200832102371
200923180181
201017147068
201116926114
201291073149
2013121972223
2014201530111
2015181840125
201682141106
2017171241107
201823124286
20191390065
2020151321126
20218880101
20229118047
202321743120
20242855268
20251457157
20265964—

What is it indicated for?

Anorganic Bone Mineral Bone Graft Materials are intended for use in filling bony voids or gaps of the skeletal system (i.e., extremities, spine, and pelvis) that are not intrinsic to the stability of the bony structure. These defects may be surgically created osseous defects or osseous defects resulting from traumatic injury to the bone.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K062200: Collagen Matrix Anorganic Bone Mineral Bone Graft Materials.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K062200

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026